Your Epigenetic editors enter clinical trials.
Epigenetic editing could help people with Primary Immunodeficiency Disorders by regulating defective immune-related genes, enhancing expression of functional proteins, correcting signaling pathways, and reprogramming immune cells, offering precise, reversible, and targeted therapeutic options.
GENE THERAPY RESEARCH
https://www.chemistryworld.com/news/epigenetic-editors-enter-clinical-trials/4021267.article
4/10/20251 min read
My post content